| | YB-1 | RPS4X | Ki67 % total | Stage | Age | Residual disease |
---|
YB-1 | correlation | 1 | 0.391** | 0.315** | −0.016 | 0.004 | −0.053 |
Sig. (2-tailed) | | <0.001 | <0.001 | 0.829 | 0.961 | 0.535 |
| N | 186 | 186 | 180 | 186 | 186 | 137 |
RPS4X | correlation | 0.391** | 1 | 0.224** | −0.180* | 0.041 | −0.193* |
Sig. (2-tailed) | <0.001 | | 0.002 | 0.013 | 0.557 | 0.022 |
| N | 186 | 190 | 183 | 190 | 190 | 141 |
- * Correlation is significant at the 0.05 level (2-tailed).
- ** Correlation is significant at the 0.01 level (2-tailed).
- Spearman correlation test were performed on clinical data, total Ki67%, YB-1, and PRS4X staining intensity observed in the intra-epithelial area of ovarian tumors. Stage was evaluated according to the FIGO classification. “Sig.” in the table represents the P-value from Spearman correlation test. N is the number of cases included in the statistical analysis.